Cajutol, Benedicto D.

HRN: 16-93-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/19/2026
03/26/2026
IV
500mg
Q8H
Amoebiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: